PhONEME - PartipatOn Ehealth MobilE. Effects of an Interactive Information and Communications Technology (ICT) Platform for Assessment and Management of Symptoms in Patients Treated for Prostate Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostate Cancer
- Sponsor
- Karolinska Institutet
- Enrollment
- 150
- Locations
- 1
- Primary Endpoint
- EORTC Prostate-specific module (QLQ-PR25) Questionnaire
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the effects of an interactive ICT-platform for use in a smartphone or tablet in patients treated with radiotherapy for prostate cancer. The hypothesis is that clinical management will be improved and costs reduced and safe and participatory care promoted, when patients report symptoms in an application which provides self-care advice and instant access to professionals.
Investigators
Ann Langius-Eklöf
PhD, RN, Professor
Karolinska Institutet
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of prostate cancer without metastases or spread to the lymph nodes,
- •will receive radiation therapy for at least five (5) weeks,
- •literacy in the Swedish language
Exclusion Criteria
- •Patients who need an interpreter at the doctor's visit
- •Patients who have a known severe cognitive impairment
Outcomes
Primary Outcomes
EORTC Prostate-specific module (QLQ-PR25) Questionnaire
Time Frame: up to 3 months after completion of radiotherapy treatment
To evaluate self-reported data in terms of symptom prevalence, characteristics and distress related to prostate cancer
Scale for Communicative and Critical Health Literacy (S-C & C HL - Swedish version)
Time Frame: up to 3 months after completion of radiotherapy treatment
To evaluate self-reported data in terms of health literacy
Questionnaire Sense of Coherence Scale (KASAM)
Time Frame: up to 3 months after completion of radiotherapy treatment
To evaluate self-reported data in terms of Sense of Coherence
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30)
Time Frame: up to 3 months after completion of radiotherapy treatment
To evaluate self-reported data in terms of health related quality of life
Questionnaire Individualized Care Scale (ICS)
Time Frame: up to 3 months after completion of radiotherapy treatment
To evaluate self-reported data in terms of individualized care as measured by the ICS
Questionnaire Scale for Functional Health Literacy (S-FHL - Swedish version)
Time Frame: up to 3 months after completion of radiotherapy treatment
To evaluate self-reported data in terms of understanding and communicating health
Secondary Outcomes
- Health care costs(up to 3 months after completion of radiotherapy treatment)